(2023)
New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles’ operation.
INSIGHTS INTO IMAGING.
14,
1
(2023)
Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
24,
19
(2023)
Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study.
JOURNAL OF YEUNGNAM MEDICAL SCIENCE.
40,
4
(2023)
How far has robot-assisted partial nephrectomy reached?.
INVESTIGATIVE AND CLINICAL UROLOGY.
64,
5
(2023)
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer.
PROSTATE INTERNATIONAL.
11,
3
(2023)
Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer.
BIOMEDICINES.
11,
7
(2023)
IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation.
FRONTIERS IN IMMUNOLOGY.
14,
(2023)
Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy.
EUROPEAN UROLOGY FOCUS.
9,
1
(2022)
Current status and clinical application of patient-derived tumor organoid model in kidney and prostate cancers.
BMB REPORTS.
56,
1
(2022)
Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions.
CANCERS.
14,
17
(2022)
A Machine Learning Approach to Predict the Probability of Brain Metastasis in Renal Cell Carcinoma Patients.
APPLIED SCIENCES-BASEL.
12,
12
(2022)
Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma.
CANCERS.
14,
10
(2022)
Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study.
CANCERS.
14,
10
(2022)
Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer.
DIAGNOSTICS.
12,
5
(2022)
Dr. Answer AI for prostate cancer: Intention to use, expected effects, performance, and concerns of urologists.
PROSTATE INTERNATIONAL.
10,
1
(2022)
Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1–2 on multiparametric magnetic resonance imaging.
PROSTATE INTERNATIONAL.
10,
1
(2022)
TRUS-Guided Target Biopsy for a PI-RADS 3-5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis.
FRONTIERS IN ONCOLOGY.
11,
(2022)
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.
FRONTIERS IN ONCOLOGY.
12,
(2022)
Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma.
CANCER RESEARCH AND TREATMENT.
54,
1
(2021)
Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer.
CANCERS.
13,
24
단행본
(2023)
과학하는 의사들.
위즈덤하우스.
단독
학술회의논문
(2020)
Assessment of agreement between two difference prostate specific antigen assay modalities.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
Identification of LIMK2 as a novel prognostic marker and therapeutic target of clear cell renal cell carcinoma.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
Pilot study for evaluating the role circulating tumor DNA as an erly predictor of response to immune check point inhibitors in patients with metastatic renal cell carcinoma.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
Prognostic Factors for Overall Survival in Patients with Clear Cell Metastatic Renal Cell Carcinoma: Model Design and Eternal Validation with Previous Models.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
The Clinical Utility of Transperineal Template-Guided Saturation Prostate Biopsy for Risk Stratification after Transrectal Ultrasound-Guided Biospy.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
gleason score upgrading according to the numbers of target biopsy cores.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
근치적 방광 절제술의 4가지 요인: 로봇 보조 근치적 방광 절제술의 초기 성적을 표준화할 수 있는 요잉느이 제안 및 수술 경험의 영향.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
단일 신장 환자들에 있어 근치적 방광 적출술 시행 시 회장 도관 요루 형성술과 요관 피부 문합술 간 수술 후 결과 비교.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
만성 신부전 환자에서 작은 신종물에 대한 치료로 부분 신 절제술과 고주파 열 치료술 간 비교.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
신문부 종양과 비 신문부 종야에 대해 로봇을 이용한 복강경하 부분 신 절제술 후 결과 비교.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
액체 생검을 이용한 한국 전립선암 환자의 유전적 변이 프로파일: 거세 저항성 발생 예측에 있어 액체 생검의 유용성.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
임상적으로 중요한 전립선암의 진단에 있어서 전립선 건강 지수와 PI-RADS 버전 2의 결합.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
전향적 코호트를 이용한 한국인 전립선암에서 적극적인 감시를 위한 엄격한 기준 적용의 임상영향 평가.
제72차 대한비뇨의학회 학술대회.
대한민국
(2020)
Detection of Prostate Cancer Using Prostate Imaging Reporting and Data System Score and Prostate-specific Antigen Density in Biopsynaive and Prior Biopsy-negative patients.
2020 KPS-APSU Joint International Symposium.
대한민국
(2020)
Necessity of Multi-care Target Biopsy in Reducing Underestimation of Prostate Cancer: Analysis with Propensity Score Matching.
2020 KPS-APSU Joint International Symposium.
대한민국
(2020)
Negative Predictive Value of MRI to Rule out Clinically Significant Prostate Cancer in Repeat Biopsy Setting: Based on Transperineal Staturation Biopsy.
2020 KPS-APSU Joint International Symposium.
대한민국
(2020)
Preoperative vs Postoperative Compensation of the Contralateral Normal Kidney in Patients Treated with Radical Nephrectomy for Renal Cell Carcinoma.
2020 KPS-APSU Joint International Symposium.
대한민국
(2020)
The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Random Biopsy.
2020 KPS-APSU Joint International Symposium.
대한민국
(2020)
Small renal mass in the NGS era: Intratumor heterogeneity and the risk of metastasis?.
KUCE 2020.
대한민국
